Engineered Micro-Pancreas (EMP) could rectify diabetes
Guardian - 23-Jul-2020Betalin's biological scaffold holds beta cells that release insulin instead of having to inject it
Nikolai Kunicher
CEO at Betalin Therapeutics
Over 10 years experience in Biotech R&D management for companies such as, ARTSaVIT and AVA Biodefender.
Previous Head of Business Development at Surgical Innovation and Technology Center, Hadassah Medical Center.
Betalin Therapeutics
Develops Engineered Micro-Pancreas (EMP) as a cell therapy solution for insulin-dependent diabetes
Details last updated 23-Jul-2020
Nikolai Kunicher News
